Evidence map›Paper›PMID 34921143›Full record

ArticleNature communications2021

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.

Cornelius H L Kürten, Aditi Kulkarni, Anthony R Cillo, Patricia M Santos, Anna K Roble, Sayali Onkar, Carly Reeder, Stephan Lang, Xueer Chen, Umamaheswar Duvvuri and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 1 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 1 synthesis or guideline pooled it, 278 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  19. Article
  20. Article

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Cornelius H L Kürten *Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-2720-0075
Aditi Kulkarni *UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Anthony R CilloUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-3213-3129
Patricia M SantosUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Anna K RobleUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-9435-4939
Sayali OnkarUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Carly ReederUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Stephan LangDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Xueer ChenDeparment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
Umamaheswar DuvvuriDepartment of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.
Seungwon KimDepartment of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.
Angen LiuDepartment of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.
Tracy TabibDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Robert LafyatisDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Jian FengUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Shou-Jiang GaoUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-6194-1742
Tullia C BrunoUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-6433-0207
Dario A A VignaliUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Xinghua LuDeparment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-8599-2269
Riyue BaoUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Lazar Vujanovic *UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-1729-8619
Robert L FerrisUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ferrisrl@upmc.edu.
University of Pittsburgh · USUniversity of Duisburg-Essen · DEUPMC Health System · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHNP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 2004 to 2026
$49.6M
Training in Cellular & Molecular Mechanisms of Tumor RejectionT32CA082084 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert J Binder, Dario AA Vignali · 1999 to 2026
$9.2M
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytesR01CA206517 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert L. Ferris, Lawrence P. Kane · 2016 to 2026
$4.6M
Interpretable deep learning models for translational medicine RenewalR01LM012011 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tanner J. Freeman, XINGHUA LU · 2015 to 2026
$3.6M
Inhibition of lysosomal flux in carcinogen-induced head and neck cancerR01DE028343 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUVVURI, UMAMAHESWAR · 2019 to 2023
$1.9M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA097190NCI NIH HHS R01 CA206517NCI NIH HHS T32 CA082084NIDCR NIH HHS R01 DE028343NLM NIH HHS R01 LM012011
6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is characterized by complex relations between stromal, epithelial, and immune cells within the tumor microenvironment (TME). To enable the development of more efficacious therapies, we aim to study the heterogeneity, signatures of unique cell populations, and cell-cell interactions of non-immune and immune cell populations in 6 human papillomavirus (HPV)

Indexed as

Cell CommunicationRNA-SeqSingle-Cell AnalysisAntigen-Presenting CellsB7-H1 AntigenCancer-Associated FibroblastsCD8-Positive T-LymphocytesEndothelial CellsEpithelial CellsGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansImmune Checkpoint ProteinsInflammationLigandsMacrophagesB7-H1 AntigenCD274 protein, humanImmune Checkpoint ProteinsLigands

Identifiers

PMID34921143
PMCPMC8683505
OpenAlexW4200189496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.